Have a question?
Please get in touch with our team in case of any queries
GLOBAL COVID-19 DIAGNOSTICS MARKET SIZE TO REACH USD 7.4 BILLION BY 2026
COVID-19 Diagnostics Market Size, Share, Trends Analysis Report by Products (Consumables and Analyzers/Instruments), End-users (Laboratories, Hospitals, Ambulatory Care Settings, and Research Institutes), Test (PCR, Antigen, and Antibody), Technology (Molecular and Immunology), and Geography (APAC, North America, Europe, Latin America, and the Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Market Trends, Competitive Market Share & Forecast, 2021-2026
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL COVID-19 DIAGNOSTICS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (Revenue) | USD 7.4 BILLION (2026) |
| CAGR | (9)% (2021–2026) |
| Base Year | 2020 |
| Forecast Year | 2021-2026 |
| Market Segments | Products (Consumables and analyzers/Instruments), End-users (Laboratories, Hospitals, Ambulatory Care Settings, and Research Institutes), Test (PCR, Antigen, and Antibody), Technology (Molecular and Immunology) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Italy, Spain, Russia, China, Japan, South Korea, Australia, India, Indonesia, Philippines, Brazil, Peru, Mexico, Argentina, Colombia, Chile, Turkey, South Africa, Iran, and Saudi Arabia |
INDUSTRY INSIGHTS
The global COVID-19 diagnostics market size is valued at USD 13 billion in 2020 and is expected to reach USD 7.4 billion by 2026. The RT-PCR testing segment constituted over 75% of the global COVID test market share. The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.
SNIPPETS
- The consumables segment is expected to reach close to USD 6 billion by 2026 on account of the increased usage of a wide array of reagents and COVID-19 test kits.
- The PCR segment is projected to touch revenue of over USD6 billion by 2026 as PCR tests are considered quick, specific, and accurate, and less prone to contamination.
- In terms of revenue, the diagnostic segment is likely to dominate the COVID-19 diagnostics market. Diagnostic labs have an extremely high capacity to handle many samples and deliver results in a short duration.
- The Asia Pacific COVID-19 test market is expected to observe high revenue during the forecast period because of the high prevalence of the coronavirus infection.
GLOBAL COVID-19 DIAGNOSTICS MARKET SEGMENTATION
This research report includes a detailed segmentation by
- Product
- End-users
- Test
- Technology
- Geography
INSIGHTS BY PRODUCT
In 2020, the consumables segment constituted over 74% of the global COVID-19 diagnostics market share. The demand for consumables, including biomarkers and reagents, including substrates, enzymes, electrolytes, specific proteins, lipids, and point-of-care (POC) test kits, is growing as they obtain quick and accurate results for diagnosing diseases, including COVID-19. The need to perform rapid testing to detect coronavirus spread across the world is driving the demand for consumables.
The analyzers/instruments COVID-19 test kits segment accounted for over 25% of the global COVID-19 testing market. This segment is growing at a relatively slower pace than consumables as it is capital intensive, and purchasing decisions for the same depends on financial resources and budget allocations. The demand for PCR analyzers is expected to grow at a steady rate, with vendors introducing diverse innovative and next-generation analyzers.
INSIGHTS BY TEST
As RT-PCR testing is considered exceptionally reliable, the segment constituted over 75% of the global COVID diagnostics market share. The market is witnessing an increasing uptake of PCR testing to deliver a reliable diagnosis in quick succession. Currently, the reverse transcription-polymerase chain reaction (RT-PCR Test) is a standard for diagnosing COVID-19. With the WHO recommending PCR testing as one of the reliable methods for COVID-19 test procedures, countries such as the US, Brazil, Russia, India, Germany, Italy, and Spain drive the demand for PCR kits the virus highly infects these regions. Antigen and antibody testing accounted for a small share of the global COVID-19 diagnostics market. These tests are considered an important factor in mass screening. However, due to a lack of specificity and sensitivity, these tests were not initially used in several countries. As the COVID-19 pandemic continues, vendors came up with advanced antibody and antigen tests, driving the COVID-19 testing market growth.
INSIGHTS BY TECHNOLOGY
The failure of several rapid diagnostics testing kits to detect the presence of the COVID-19 virus in several countries has led to the development of molecular-based-PCR COVID testing. The share of molecular diagnostic test makers has increased drastically, with the WHO declaring RT-PCR as the standard test for COVID-19 diagnosis. This trend is followed in several developed, developing, and underdeveloped countries, thereby generating a high demand for molecular diagnostic testing. The immunoassay segment accounted for over 24% of the global market share in 2020. These tests are conducted in real-time on those with maximum exposure to the COVID-19 virus, especially healthcare professionals and medical practitioners.
Immunoassay tests received a setback in most countries due to their limited specificity and sensitivity. They produced several false positive and false negative results, which made people look for alternative tests. However, vendors came up with high sensitivity and specific immunoassay tests with superior results.
INSIGHTS BY END-USERS
In most countries, diagnostic laboratories, which include standard and public health organizations, have played a significant role in detecting COVID-19. The demand for standalone laboratories is growing gradually owing to the prevalence of pandemic, epidemic conditions, or the outbreak of unexpected infectious diseases, requiring immediate diagnosis of the diseases for a large population in a shorter time. The end-user hospitals segment has played a major role in COVID-19 testing since its outbreak. A majority of hospitals have their own in-house laboratories to conduct COVID-19 tests, which help them to admit and monitor COVID-19 patients. Hence the segment is witnessing a high demand for COVID-19 testing kits. The demand for COVID-19 diagnostic kits from ambulatory care settings increased in developed countries as these settings accommodated several asymptomatic patients.
INSIGHTS BY GEOGRAPHY
APAC emerged as the largest COVID-19 diagnostics market and is likely to retain its position during the forecast year due to the widespread COVID-19 infection in the population. Several countries in the region, especially India, where the number of people infected with coronavirus stood at 8.5 million in October 2020, are likely to increase mass COVID-19 testing, thereby increasing the demand. The presence of a large population, poor living standards, and inadequate medical infrastructure are the major factors responsible for the infection's high prevalence. However, increased mass COVID-19 testing initiatives and high investments in public healthcare services are likely to favor the COVID-19 testing market. China, Japan, India, South Korea, and Australia are the major revenue contributors to the APAC COVID-19 diagnostics market. Several countries preferred using PCR-based COVID testing due to their higher accuracy than serological tests. Australia and New Zealand have increased their COVID-19 testing capacities to reduce the impact of the disease.
In 2020, North America accounted for a share of 25% of the global COVID-19 diagnostics market. The US, with developed healthcare infrastructure, is still struggling to contain the spread of the virus. This region has recorded the second-highest tests after APAC. The countries in the region are focusing on the high use of antibody tests and antigen tests. The US government plans to distribute 150 million rapid COVID-19 test kits from Abbott laboratories.
INSIGHTS BY VENDORS
The global coronavirus diagnostics market is highly dynamic with the presence of several global, regional, and local company profiles, offering a diverse range of analyzers, test kits, assays, and reagents to perform COVID-19 tests. Abbott, BD, Danaher, F. Hoffmann-La Roche, Siemens Healthineers, and Thermo Fisher Scientific are the major player in the diagnostics market. Global market players focus on developing innovative products, producing COVID-19 vaccines, and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.
The COVID-19 diagnostics market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Product
- Consumables
- Analyzers/Instruments
By Test
- PCR
- Antigen
- Antibody
By Technology
- Molecular
- Immunology
By End-user
- Laboratories
- Hospitals
- Ambulatory Care Settings
- Research Institutes
By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Indonesia
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Peru
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- Turkey
- Iran
SNAPSHOT
The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2020–2026.
The following factors are likely to contribute to the growth of the COVID-19 diagnostics market during the forecast period:
- Increased Demand for Mass Testing
- Demand for Molecular Diagnostics due to Covid-19 Pandemic
- Unavailability of Specific Medicines/ Vaccines
Base Year: 2020
Forecast Year: 2021–2026
The study considers the present scenario of the COVID-19 diagnostics market and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
- Abbott
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Siemens Healthineers
- Hoffmann-La Roche
- Thermo Fisher Scientific
- Danaher
- BD
Other Prominent Vendors
- Abingdon Health
- Business Overview
- Product Offerings
- ACCESS BIO
- Assure Tech. (Hangzhou)
- Autobio Diagnostics
- Advaite
- Babson Diagnostics
- Beijing Wantai Biological
- Biomerica
- bioMérieux
- Biopanda Reagents
- Biocerna
- Biocan Diagnostics
- BioMedomics
- Clinical Reference Laboratory
- Cellex
- The Center for Chest Diseases and Prevention (CDC)
- CTK Biotech
- DiaSorin
- Diazyme Laboratories
- Erba Mannheim
- Edinburgh Genetics
- Eurofins Scientific
- GenScript
- Healgen Scientific
- Hangzhou AllTest Biotech
- Hangzhou Biotest Biotech
- Jiangsu Well Biotech
- Kabla Diagnostics
- Luminex
- Meridian Bioscience
- Megna Health
- Microgen
- MP Biomedicals
- Nova Tech Immunodiagnostica
- NOWDiagnostics
- Quotient
- QIAGEN
- Quidel
- Sekisui Diagnostics
- Sinocare
- SureScreen Diagnostics
- Salofy Oy
- Shenzhen New Industries Biomedical Engineering (SNIBE)
- Sysmex
- SEASUN BIOMATERIALS
- Vibrant America
- Warrior Diagnostics
- Xiamen Biotime Biotechnology
- Zuhai Livzon Diagnostic
By Product
- Consumables
- Analyzers/Instruments
By Test
- PCR
- Antigen
- Antibody
By Technology
- Molecular
- Immunology
By End-user
- Laboratories
- Hospitals
- Ambulatory Care Settings
- Research Institutes
By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Indonesia
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Peru
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- Turkey
- Iran
Frequently Asked Questions
What is the growth forecast of global COVID-19 diagnostics market size in 2026?
What is the RT-PCR COVID-19 testing market share?
Which are the key perspectives that key vendors are leveraging to move businesses to a new growth trajectory?
What kinds of diagnostic tests are available for the coronavirus disease?
Who are the key players in the COVID 19 diagnostics market?
List Of Exhibits
Exhibit 1 Segmentation of Global Covid-19 Diagnostic Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 COVID-19 Diagnostics: Supply Chain Analysis
Exhibit 4 Impact of Demand for Mass Testing
Exhibit 5 Impact of Raise of Second Wave of Covid-19
Exhibit 6 Impact of High Demand for Molecular Diagnostics
Exhibit 7 Comparison of Regions Conducting Molecular PCR Tests & Other Tests
Exhibit 8 Impact of Unavailability of Specific Medicines/Vaccines
Exhibit 9 Comparison of the Total infectious Disease Market to Covid-19 market 2021 (billion)
Exhibit 10 Essential Role of Laboratory Diagnostics in Covid-19 Infection
Exhibit 11 Impact of More Product Launches Combined with EUA
Exhibit 12 Impact of Widespread Practice of Testing to Control COVID-19
Exhibit 13 Impact of Challenges in Testing COVID-19 in Developing Countries
Exhibit 14 Impact of Preventive Measures, Lockdown, and Fastrack of Vaccine Development
Exhibit 15 Impact of Increase in Proportion of False Positive and Negative Tests
Exhibit 16 Impact of False Positive & Negative Results For 100 samples
Exhibit 17 Global COVID-19 Diagnostics Market 2020–2026 ($ billion)
Exhibit 18 Global COVID-19 Diagnostics Market by Product
Exhibit 19 Global COVID-19 Diagnostics Market by Tests
Exhibit 20 Global COVID-19 Diagnostics Market by Technology
Exhibit 21 Global COVID-19 Diagnostics Market by End-User
Exhibit 22 Global COVID-19 Diagnostics Market by Geography
Exhibit 23 Five Forces Analysis 2020
Exhibit 24 Incremental Growth by Segment 2020 & 2026
Exhibit 25 Global COVID-19 Diagnostics Market by Product
Exhibit 26 Global COVID-19 Diagnostics Market by Product: Incremental Growth
Exhibit 27 Global COVID-19 Diagnostics Market by Product: Absolute Growth
Exhibit 28 Global COVID-19 Diagnostics Market by Consumables: Increment Growth Versus Absolute Growth
Exhibit 29 Global COVID-19 Diagnostics Market by Consumables 2020–2026 ($ billion)
Exhibit 30 Incremental Growth by Geography 2020 & 2026
Exhibit 31 Global COVID-19 Testing Market by Analyzers: Increment Growth Versus Absolute Growth
Exhibit 32 Global COVID-19 Diagnostics Market – Analyzers & Software 2020–2026 ($ billion)
Exhibit 33 Incremental Growth by Geography 2020 & 2026
Exhibit 34 Incremental Growth by Test 2020 & 2026
Exhibit 35 Global Covid-19 Diagnostics Market by Test Type
Exhibit 36 Global COVID-19 Diagnostics Market by Test Type: Incremental Growth
Exhibit 37 Global COVID-19 Diagnostics Market by Test Type: Absolute Growth
Exhibit 38 Global COVID-19 Testing Market by PCR Test: Increment Growth Versus Absolute Growth
Exhibit 39 Global COVID-19 Diagnostics – PCR Market 2020–2026 ($ billion)
Exhibit 40 Incremental Growth by Segment 2020 & 2026
Exhibit 41 GlobaTesting Market by Antigen Test: Increment Growth Versus Absolute Growth
Exhibit 42 Global COVID-19 Diagnostics – Antigen Test Market 2020–2026 ($ billion)
Exhibit 43 Incremental Growth by Geography 2020 & 2026
Exhibit 44 Global Covid-19 Testing Market by Antibody Testing: Increment Growth Versus Absolute Growth
Exhibit 45 Global COVID-19 Diagnostics Market – Antibody Testing 2020–2026 ($ billion)
Exhibit 46 Incremental Growth by Application 2020 & 2026
Exhibit 47 Incremental Growth by Technology2020 & 2026
Exhibit 48 Global Covid-19 Diagnostics Market by Technology
Exhibit 49 Global COVID-19 Diagnostics Market by Technology: Incremental Growth
Exhibit 50 Global COVID-19 Diagnostics Market by Technology: Absolute Growth
Exhibit 51 Global COVID-19 Testing Market by Molecular: Increment Growth Versus Absolute Growth
Exhibit 52 Global COVID-19 Diagnostics Market – Molecular Diagnostics 2020–2026 ($ billion)
Exhibit 53 Incremental Growth by Geography 2020 & 2026
Exhibit 54 Global COVID-19 Testing Market by Immunoassay: Increment Growth Versus Absolute Growth
Exhibit 55 Global COVID-19 Diagnostics – Immunoassay Market 2020–2026 ($ billion)
Exhibit 56 Incremental Growth by Geography 2020 & 2026
Exhibit 57 Incremental Growth by Segment 2020 & 2026
Exhibit 58 Global Infectious Diseases Diagnostics Market by Test
Exhibit 59 Global COVID-19 Diagnostics Market by End-User: Incremental Growth
Exhibit 60 Global COVID-19 Diagnostics Market by End-User: Absolute Growth
Exhibit 61 Global COVID-19 Testing Market by Diagnostic Laboratories: Increment Growth Versus Absolute Growth
Exhibit 62 Global COVID-19 Diagnostics Market – Diagnostic Laboratories 2020–2026 ($ billion)
Exhibit 63 Global Covid-19 Testing Market by Hospitals: Increment Growth Versus Absolute Growth
Exhibit 64 Global COVID-19 Diagnostics Market- Hospitals 2020–2026 ($ billion)
Exhibit 65 Global COVID-19 Testing Market by Ambulatory Care Settings: Increment Growth Versus Absolute Growth
Exhibit 66 Global COVID-19 Ambulatory Care Settings Market 2020–2026 ($ billion)
Exhibit 67 Global COVID-19 Testing Market by Research Institutes: Increment Growth Versus Absolute Growth
Exhibit 68 Global COVID-19 Diagnostics Market- Research Institutes 2020–2026 ($ billion)
Exhibit 69 Incremental Growth by Geography 2020 & 2026
Exhibit 70 Global Covid-19 Diagnostics Market by Geography
Exhibit 71 COVID-19 Diagnostics Market in APAC: Key Countries 2020 ($ billion)
Exhibit 72 COVID-19 Diagnostics Market in APAC: Incremental Growth versus Absolute Growth Comparison
Exhibit 73 COVID-19 Diagnostics Market in APAC 2020–2026 ($ billion)
Exhibit 74 Incremental Growth in APAC 2020 & 2026
Exhibit 75 COVID-19 Diagnostics Market in China 2020–2026 ($ billion)
Exhibit 76 Daily Nucleic acid Testing Capacity (In Thousands)
Exhibit 77 COVID-19 Diagnostics Market in India 2020–2026 ($ billion)
Exhibit 78 Types of Test Conducted in Japan (million)
Exhibit 79 COVID-19 Diagnostics Market in Japan 2020–2026 ($ billion)
Exhibit 80 COVID-19 Diagnostics Market in South Korea 2020–2026 ($ billion)
Exhibit 81 COVID-19 Diagnostics Market in Australia 2020–2026 ($ billion)
Exhibit 82 COVID-19 Diagnostics Market in Indonesia 2020–2026 ($ billion)
Exhibit 83 COVID-19 Diagnostics Market in Philippines 2020–2026 ($ billion)
Exhibit 84 COVID-19 Diagnostics Market in North America: Key Countries 2020 ($ billion)
Exhibit 85 COVID-19 Diagnostics Market in North America: Incremental Growth versus Absolute Growth Comparison
Exhibit 86 COVID-19 Diagnostics Market in North America 2020–2026 ($ billion)
Exhibit 87 Incremental Growth in North America 2020 & 2026
Exhibit 88 COVID-19 Diagnostics Market in US 2020–2026 ($ billion)
Exhibit 89 COVID-19 Diagnostics Market in Canada 2020–2026 ($ billion)
Exhibit 90 COVID-19 Diagnostics Market in Europe: Key Countries 2020 ($ billion)
Exhibit 91 COVID-19 Diagnostics Market in Europe: Incremental Growth versus Absolute Growth Comparison
Exhibit 92 COVID-19 Diagnostics Market in Europe 2020–2026 ($ billion)
Exhibit 93 Incremental Growth in Europe 2020 & 2026
Exhibit 94 COVID-19 Diagnostics Market in Russia 2020–2026 ($ billion)
Exhibit 95 COVID-19 Diagnostics Market in UK 2020–2026 ($ billion)
Exhibit 96 COVID-19 Diagnostics Market in Germany 2020–2026 ($ billion)
Exhibit 97 COVID-19 Diagnostics Market in Spain 2020–2026 ($ billion)
Exhibit 98 COVID-19 Diagnostics Market in France 2020–2026 ($ billion)
Exhibit 99 COVID-19 Diagnostics Market in Italy 2020–2026 ($ billion)
Exhibit 100 COVID-19 Diagnostics Market in Middle East & Africa: Key Countries 2020 ($ billion)
Exhibit 101 COVID-19 Diagnostics Market in the Middle East and Africa: Incremental Growth versus Absolute Growth Comparison
Exhibit 102 COVID-19 Diagnostics Market in Middle East & Africa 2020–2026 ($ billion)
Exhibit 103 Incremental Growth in Middle East and Africa 2020 & 2026
Exhibit 104 COVID-19 Diagnostics Market in Turkey 2020–2026 ($ billion)
Exhibit 105 COVID-19 Diagnostics Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 106 COVID-19 Diagnostics Market in South Africa 2020–2026 ($ billion)
Exhibit 107 COVID-19 Diagnostics Market in Iran 2020–2026 ($ billion)
Exhibit 108 Latin America Countries -Tests per 1000
Exhibit 109 COVID-19 Diagnostics Market in Latin America: Key Countries 2020 ($ billion
Exhibit 110 COVID-19 Diagnostics Market in Latin America: Incremental Growth versus Absolute Growth Comparison
Exhibit 111 COVID-19 Diagnostics Market in Latin America 2020–2026 ($ billion)
Exhibit 112 Incremental Growth in Latin America 2020 & 2026
Exhibit 113 COVID-19 Diagnostics Market in Brazil 2020–2026 ($ billion)
Exhibit 114 COVID-19 Diagnostics Market in Peru 2020–2026 ($ billion)
Exhibit 115 COVID-19 Diagnostics Market in Columbia 2020–2026 ($ billion)
Exhibit 116 COVID-19 Diagnostics Market in Chile 2020–2026 ($ billion)
Exhibit 117 COVID-19 Diagnostics Market in Mexico 2020–2026 ($ billion)
Exhibit 118 COVID-19 Diagnostics Market in Argentina 2020–2026 ($ billion)
Exhibit 119 Recent initiatives of ACT-Accelerator
Exhibit 120 Abbott: Sales Breakdown by Segments in 2018-19 ($ million)
Exhibit 121 Abbott: Net Sales 2017-19 ($ million)
Exhibit 122 Abbott: Net Sales Breakdown by Diagnostic Product Segment 2018-19 ($ million)
Exhibit 123 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($billion)
Exhibit 124 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($billion)
Exhibit 125 Thermo Fisher Scientific: Revenue 2017-2019 ($ million)
Exhibit 126 Thermo Fisher Scientific: R&D Expenditure 2017-2019 ($ million)
Exhibit 127 Thermo Fisher Scientific: Revenue by Geography 2019 (%)
Exhibit 128 Danaher: Revenue by Segment 2018 &2019 ($ million)
Exhibit 129 Danaher: Net Sales 2017-2019 ($ million)
Exhibit 130 Danaher: Revenue by Geography 2019
Exhibit 131 BD Revenue by Segment 2017- 2019 ($ million)
Exhibit 132 BD: Research& Development 2017-2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Commonly Used COVID-19-PCR-Based Test Kit
Table 4 Commonly Used COVID-19 -PCR Based Test Kit
Table 5 COVID-19 Vaccine Candidates in Phase1-3 Trials and Pre-Clinical Stages of Development and Research
Table 6 PCR -Advantages and Disadvantages
Table 7 Types of Serological Tests
Table 8 WHO- COVID-19 Reference Laboratories
Table 9 State Wise Tests Conducted
Table 10 FDA Approved Key Manufacturers of COVID-19 Diagnostic Kits for the US
Table 11 African Countries -COVID-19 Testing Data (As of (2020- August mid)
Table 12 Key Companies Response to Covid-19 Pandemic
Table 13 F. Hoffmann-La Roche COVID-19 Tests Portfolio
Table 14 Abbott: Major Product Offerings
Table 15 Siemens Healthineers: Major Product Offerings
Table 16 F. Hoffmann-LaRoche: Major Product Offerings
Table 17 Thermo Fisher Scientific: Major Product Offerings
Table 18 Danaher: Major Product Offerings
Table 19 BD: Major Product Offerings
Table 20 Abingdon Health: Major Product Offerings
Table 21 ACCESS BIO: Major Product Offerings
Table 22 Assure Tech. (Hangzhou): Major Product Offerings
Table 23 Autobio: Major Product Offerings
Table 24 Advaite: Major Product Offerings
Table 25 Babson Diagnostics: Major Product Offerings
Table 26 Beijing Wantai Biological: Major Product Offerings
Table 27 Biomerica: Major Product Offerings
Table 28 bioMérieux: Major Product Offerings
Table 29 Biopanda Reagents: Major Product Offerings
Table 30 Biocerna: Major Product Offerings
Table 31 Biocan Diagnostics: Major Product Offerings
Table 32 BioMedomics: Major Product Offerings
Table 33 Clinical Reference Laboratory: Major Product Offerings
Table 34 Cellex: Major Product Offerings
Table 35 CDC: Major Product Offerings
Table 36 CTK Biotech: Major Product Offerings
Table 37 DiaSorin: Major Product Offerings
Table 38 Diazyme Laboratories: Major Product Offerings
Table 39 Erba Mannheim: Major Product Offerings
Table 40 Edinburgh Genetics: Major Product Offerings
Table 41 Eurofins Scientific: Major Product Offerings
Table 42 GenScript: Major Product Offerings
Table 43 Healgen Scientific: Major Product Offerings
Table 44 Hangzhou AllTest Biotech: Major Product Offerings
Table 45 Hangzhou Biotest Biotech: Major Product Offerings
Table 46 Jiangsu Well Biotech: Major Product Offerings
Table 47 Kabla Diagnostics: Major Product Offerings
Table 48 Luminex: Major Product Offerings
Table 49 Meridian Bioscience: Major Product Offerings
Table 50 Megna Health: Major Product Offerings
Table 51 Microgen: Major Product Offerings
Table 52 MP Biomedicals: Major Product Offerings
Table 53 Nova Tech Immunodiagnostica: Major Product Offerings
Table 54 NOWDiagnostics: Major Product Offerings
Table 55 Quotient: Major Product Offerings
Table 56 Qiagen: Major Product Offerings
Table 57 Quidel: Major Product Offerings
Table 58 Sekisui Diagnostics: Major Product Offerings
Table 59 Sinocare: Major Product Offerings
Table 60 SureScreen Diagnostics: Major Product Offerings
Table 61 Salofy Oy: Major Product Offerings
Table 62 Snibe Diagnostics: Major Product Offerings
Table 63 Sysmex: Major Product Offerings
Table 64 SEASUN BIOMATERIALS: Major Product Offerings
Table 65 Vibrant America: Major Product Offerings
Table 66 Warrior Diagnostics: Major Product Offerings
Table 67 Xiamen Biotime Biotechnology: Major Product Offerings
Table 68 Zuhai Livzon Diagnostics: Major Product Offerings
Table 69 Global Covid-19 Diagnostics Market by Geography 2020−2026 ($ billion)
Table 70 Global Covid-19 Diagnostics Market by Geography 2020−2026 ($ billion)
Table 71 Global Covid-19 Diagnostics Market Test Type 2019−2025 ($ billion)
Table 72 Global Covid-19 Diagnostics Market by Test Type 2019−2025 (%)
Table 73 Global Covid-19 Diagnostics Market Product Type 2020−2026 ($ billion)
Table 74 Global Covid-19 Diagnostics Market by Product 2020−2026 (%)
Table 75 Global Covid-19 Diagnostics Market End-User 2020−2026 ($ billion)
Table 76 Global Covid-19 Diagnostics Market by End-User 2020−2026 (%)
Table 77 Global Covid-19 Diagnostics Market Technology 2020−2026 ($ billion)
Table 78 Global Covid-19 Diagnostics Market by Technology 2020−2026 (%)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 COVID-19 Impact on Global Supply Chain of COVID-19 Diagnostics
7.2.1 Overview
7.2.2 Bridging Supply-Demand Gap of COVID-19 Diagnostics
8 Market Opportunities & Trends
8.1 Increase In Demand For Mass Testing
8.2 Raise Of Second Wave Of Covid-19
8.3 High Demand For Molecular Diagnostics
9 Market Growth Enablers
9.1 Unavailability Of Specific Medicines/Vaccines
9.2 More Product Launches Combined With EUA
9.3 Widespread Practice Of Testng To Control COVID-19
10 Market Restraints
10.1 Challenges In Testing Covid-19 In Developing Countries
10.2 Preventive Measures And Fastrack Of Vaccine Development
10.3 Increase In Proportion Of False Positive And Negative Tests
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product
11.2.2 Test
11.2.3 Technology
11.2.4 End-User
11.2.5 Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Consumables: Segmentation By Geography
12.4 Analyzers & Software
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Analyzers: Segmentation By Geography
13 Test
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 PCR
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 PCR: Segmentation By Geography
13.4 Antigen Test
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Antigen Test: Segmentation By Geography
13.5 Antibody Testing
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Antibody Testing: Segmentation By Geography
14 Technology
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Molecular
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Molecular Diagnostics: Segmentation By Geography
14.4 Immunoassay
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Immuno Diagnostics: Segmentation By Geography
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Diagnostic Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Ambulatory Care Settings
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Research Institutes
15.6.1 Market Overview
15.6.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 India: Market Size & Forecast
17.3.3 Japan: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 Australia: Market Size & Forecast
17.3.6 Indonesia: Market Size & Forecast
17.3.7 Philippines: Market Size & Forecast
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 US: Market Size & Forecast
18.3.2 Canada: Market Size & Forecast
19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Russia: Market Size & Forecast
19.3.2 UK: Market Size & Forecast
19.3.3 Germany: Market Size & Forecast
19.3.4 Spain: Market Size & Forecast
19.3.5 France: Market Size & Forecast
19.3.6 Italy: Market Size & Forecast
20 Middle East And Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 South Africa: Market Size & Forecast
20.3.4 Iran: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Peru: Market Size & Forecast
21.3.3 Columbia: Market Size & Forecast
21.3.4 Chile: Market Size & Forecast
21.3.5 Mexico: Market Size & Forecast
21.3.6 Argentina: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.1.1 Competitive Scenario
22.2 Vendors Focus on Accelerating Production & Streamlining Supply Chain of COVID-19 Diagnostics
22.2.1 WHO’s Efforts/Initiatives to Increase Supply of COVID-19 Tests for LMICs
22.3 Market Share Analysis
22.3.1 Abbott
22.3.2 Siemens Healthineers
22.3.3 F. Hoffmann-La Roche
22.3.4 Thermo Fisher Scientific
22.3.5 Danaher
22.3.6 BD
23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Siemens Healthineers
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 F. Hoffmann-La Roche
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Thermo Fisher Scientific
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Danaher
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 BD
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
24 Other Prominent Vendors
24.1 Abingdon Health
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 ACCESS BIO
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Assure Tech. (Hangzhou)
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Autobio
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Advaite
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Babson Diagnostics
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Beijing Wantai Biological
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Biomerica
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 bioMérieux
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Biopanda Reagents
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Biocerna
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Biocan Diagnostics
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 BioMedomics
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Clinical Reference Laboratory
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Cellex
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 The Centers for Disease Control and Prevention (CDC)
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 CTK Biotech
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 DiaSorin
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 Diazyme Laboratories
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Erba Mannheim
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Edinburgh Genetics
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Eurofins Scientific
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 GenScript
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 Healgen Scientific
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 Hangzhou AllTest Biotech
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Hangzhou Biotest Biotech
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 Jiangsu Well Biotech
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 Kabla Diagnostics
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Luminex
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 Meridian Bioscience
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 Megna Health
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 Microgen
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 MP Biomedicals
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 NovaTech Immunodiagnostica
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 NOWDiagnostics
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 Quotient
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Qiagen
24.37.1 Business Overview
24.37.2 Product Offerings
24.38 Quidel
24.38.1 Business Overview
24.38.2 Product Offerings
24.39 Sekisui Diagnostics
24.39.1 Business Overview
24.40 Sinocare
24.40.1 Business Overview
24.40.2 Product Offerings
24.41 SureScreen Diagnostics
24.41.1 Business Overview
24.41.2 Product Offerings
24.42 Salofa Oy
24.42.1 Business Overview
24.42.2 Product Offerings
24.43 Snibe Diagnostics
24.43.1 Business Overview
24.43.2 Product Offerings
24.44 SYSMEX
24.44.1 Business Overview
24.44.2 Product Offerings
24.45 SEASUN BIOMATERIALS
24.45.1 Business Overview
24.45.2 Product Offerings
24.46 Vibrant America
24.46.1 Business Overview
24.46.2 Product Offerings
24.47 Warrior Diagnostics
24.47.1 Business Overview
24.47.2 Product Offerings
24.48 Xiamen Biotime BiotechnOlogy
24.48.1 Business Overview
24.48.2 Product Offerings
24.49 Zuhai Livzon Diagnostics
24.49.1 Business Overview
24.49.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market By Geography
26.2 Market By Test Type
26.3 Market By Product Type
26.4 Market By End-User
26.5 Market By Technology
27 Appendix
27.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the growth forecast of global COVID-19 diagnostics market size in 2026?
What is the RT-PCR COVID-19 testing market share?
Which are the key perspectives that key vendors are leveraging to move businesses to a new growth trajectory?
What kinds of diagnostic tests are available for the coronavirus disease?
Who are the key players in the COVID 19 diagnostics market?
Other RELATED Reports
U.S. Point-of-Care Diagnostics Market - Industry Outlook and Forecast 2019-2024
Published : February 2019
Infectious Disease Diagnostics Market - Global Outlook and Forecast 2020-2025
Published : July 2020
